SEARCH

SEARCH BY CITATION

References

  • Alizadeh, A.A., Eisen, M.B., Davis, R.E., Ma, C., Lossos, I.S., Rosenwald, A., Boldrick, J.C., Sabet, H., Tran, T., Yu, X., Powell, J.I., Yang, L., Marti, G.E., Moore, T., Hudson, Jr, J., Lu, L., Lewis, D.B., Tibshirani, R., Sherlock, G., Chan, W.C., Greiner, T.C., Weisenburger, D.D., Armitage, J.O., Warnke, R., Levy, R., Wilson, W., Grever, M.R., Byrd, J.C., Botstein, D., Brown, P.O. & Staudt, L.M. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403, 503511.
  • Atra, A., Imeson, J.D., Hobson, R., Gerrard, M., Hann, I.M., Eden, O.B., Carter, R.L. & Pinkerton, C.R. (2000) Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol. British Journal of Cancer, 82, 13961402.
  • Beer, S., Zetterberg, A., Ihrie, R.A., McTaggart, R.A., Yang, Q., Bradon, N., Arvanitis, C., Attardi, L.D., Feng, S., Ruebner, B., Cardiff, R.D. & Felsher, D.W. (2004) Developmental context determines latency of MYC-induced tumorigenesis. PLoS Biology, 2, e332.
  • Borkhardt, A., Wuchter, C., Viehmann, S., Pils, S., Teigler-Schlegel, A., Stanulla, M., Zimmermann, M., Ludwig, W.D., Janka-Schaub, G., Schrappe, M. & Harbott, J. (2002) Infant acute lymphoblastic leukemia – combined cytogenetic, immunophenotypical and molecular analysis of 77 cases. Leukemia, 16, 16851690.
  • Bowman, W.P., Shuster, J.J., Cook, B., Griffin, T., Behm, F., Pullen, J., Link, M., Head, D., Carroll, A., Berard, C. & Murphy, S. (1996) Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study. Journal of Clinical Oncology, 14, 12521261.
  • Brugieres, L., Deley, M.C., Pacquement, H., Meguerian-Bedoyan, Z., Terrier-Lacombe, M.J., Robert, A., Pondarre, C., Leverger, G., Devalck, C., Rodary, C., Delsol, G. & Hartmann, O. (1998) CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology. Blood, 92, 35913598.
  • Cairo, M.S., Krailo, M.D., Morse, M., Hutchinson, R.J., Harris, R.E., Kjeldsberg, C.R., Kadin, M.E., Radel, E., Steinherz, L.J., Morris, E., Finlay, J.L. & Meadows, A.T. (2002) Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate (‘Orange’) in children with advanced non-lymphoblastic non-Hodgkin lymphoma: a Children's Cancer Group Report. Leukemia, 16, 594600.
  • Cairo, M.S., Sposto, R., Perkins, S.L., Meadows, A.T., Hoover-Regan, M.L., Anderson, J.R., Siegel, S.E., Lones, M.A., Tedeschi-Blok, N., Kadin, M.E., Kjeldsberg, C.R., Wilson, J.F., Sanger, W., Morris, E., Krailo, M.D. & Finlay, J.L. (2003) Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience. British Journal of Haematology, 120, 660670.
  • Chessells, J.M., Hall, E., Prentice, H.G., Durrant, J., Bailey, C.C. & Richards, S.M. (1998) The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties. Leukemia, 12, 463473.
  • Cox, D.R. (1972) Regression models and life tables. Journal of the Royal Statistical Society, 34, 187220.
  • Dave, B.J., Weisenburger, D.D., Higgins, C.M., Pickering, D.L., Hess, M.M., Chan, W.C. & Sanger, W.G. (2004) Cytogenetics and fluorescence in situ hybridization studies of diffuse large B-cell lymphoma in children and young adults. Cancer Genetics and Cytogenetics, 153, 115121.
  • Eden, O.B., Hann, I., Imeson, J., Cotterill, S., Gerrard, M. & Pinkerton, C.R. (1992) Treatment of advanced stage T cell lymphoblastic lymphoma: results of the United Kingdom Children's Cancer Study Group (UKCCSG) protocol 8503. British Journal of Haematology, 82, 310316.
  • Frost, M., Newell, J., Lones, M.A., Tripp, S.R., Cairo, M.S. & Perkins, S.L. (2004) Comparative immunohistochemical analysis of pediatric Burkitt lymphoma and diffuse large B-cell lymphoma. American Journal of Clinical Pathology, 121, 384392.
  • Gray, R.J. (1988) A class of K-sample tests for comparing the cumulative incidence of a competing risk. Annals of Statistics, 16, 11411154.
  • Jaffe, E.S., Harris, N.L., Stein, H. & Vardiman, J. (2001) WHO Classification, Tumours of Haematopoietic and Lymphoid Tissue. IARC Press, Lyon.
  • Kaatsch, P. & Spix, C. (2004) German Childhood Cancer Registry, Annual Report 2003. German Childhood Cancer Registry, Mainz, Germany.
  • Kalbfleisch, J.D. & Prentice, R.L. (1980) The Statistical Analysis of Failure Time Data, pp. 163188. John Wiley, New York, NY.
  • Kaplan, E.L. & Meier, P. (1958) Non-parametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457481.
  • Kuppers, R., Klein, U., Hansmann, M.L. & Rajewsky, K. (1999) Cellular origin of human B-cell lymphomas. New England Journal of Medicine, 341, 15201529.
  • Le Deley, M.C., Reiter, A., Williams, D., Rosolen, A., Seidemann, K., Pinkerton, C., Patte, C. & Brugieres, L. (1999) Prognostic factors in childhood anaplastic large cell lymphoma (ALCL), results of the European Intergroup Study (abstract). Annals of Oncology, 10, 28.
  • Link, M.P., Shuster, J.J., Donaldson, S.S., Berard, C.W. & Murphy, S.B. (1997) Treatment of children and young adults with early-stage non-Hodgkin's lymphoma. New England Journal of Medicine, 337, 12591266.
  • Lister, T.A., Crowther, D., Sutcliffe, S.B., Glatstein, E., Canellos, G.P., Young, R.C., Rosenberg, S.A., Coltman, C.A. & Tubiana, M. (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. Journal of Clinical Oncology, 7, 16301636.
  • Mantel, E. (1966) Evaluation of survival data and tow new rank order statistics arising in its consideration. Cancer Chemotherapy Reports, 50, 163170.
  • Marky, I., Bjork, O., Forestier, E., Jonsson, O.G., Perkkio, M., Schmiegelow, K., Storm-Mathiesen, I. & Gustafsson, G. (2004) Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology. Journal of Pediatric Hematology/Oncology, 26, 555560.
  • Murphy, S.B. (1980) Classification, staging and end results of treatment of childhood non-Hodgkin lymphomas: dissimilarities from lymphomas in adults. Seminars in Oncology, 7, 332339.
  • Natkunam, Y., Lossos, I.S., Taidi, B., Zhao, S., Lu, X., Ding, F., Hammer, A.S., Marafioti, T., Byrne, Jr, G.E., Levy, S., Warnke, R.A. & Levy, R. (2005) Expression of the human germinal center-associated lymphoma (HGAL) protein, A new marker of germinal center B-cell derivation. Blood, 105, 39793986.
  • Oschlies, I., Schirmacher, J., Krams, M., Zimmermann, M., Reiter, A. & Parwaresch, R. (2003) The immunophenotype and genotype of pediatric diffuse large B-cell lymphoma differs from that of adult B-cell lymphomas (abstract). Journal of Pediatric Hematology/Oncology, 25, S3.
  • Patte, C., Kalifa, C., Flamant, F., Hartmann, O., Brugieres, L., Valteau-Couanet, D., Bayle, C., Caillaud, J.M. & Lemerle, J. (1992) Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma. Medical and Pediatric Oncology, 20, 105113.
  • Patte, C., Auperin, A., Michon, J., Behrendt, H., Leverger, G., Frappaz, D., Lutz, P., Coze, C., Perel, Y., Raphael, M. & Terrier-Lacombe, M.J. (2001) The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood, 97, 33703379.
  • Percy, C.L., Smith, M.A., Linet, M., Lynn, A., Ries, L.A.G. & Friedman, D. (1999) Lymphomas and reticuloendothelial neoplasms. In: Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995 (ed. by L.A.G.Ries, M.A.Smith & J.G.Gruney), pp. 3549. National Cancer Institute, SEER Program, Bethesda, MD.
  • Pillon, M., Di Tullio, M.T., Garaventa, A., Cesaro, S., Putti, M.C., Favre, C., Lippi, A., Surico, G., Di Cataldo, A., D'Amore, E., Zanesco, L. & Rosolen, A. (2004) Long-term results of the first Italian Association of Pediatric Hematology and Oncology protocol for the treatment of pediatric B-cell non-Hodgkin lymphoma (AIEOP LNH92). Cancer, 101, 385394.
  • Pui, C.H., Boyett, J.M., Relling, M.V., Harrison, P.L., Rivera, G.K., Behm, F.G., Sandlund, J.T., Ribeiro, R.C., Rubnitz, J.E., Gajjar, A. & Evans, W.E. (1999) Sex differences in prognosis for children with acute lymphoblastic leukemia. Journal of Clinical Oncology, 17, 818824.
  • Pusill-Wachtsmuth, B., Oschlies, I., Zimmermann, M., Ludwig, W.-D., Parwaresch, R., Mann, G., Schrappe, M., Riehm, H. & Reiter, A. (2003) Prognostic factors in childhood T-cell lymphoblastic lymphoma treated in the three consecutive NHL-BFM studies (abstract). Pediatric Hematology/Oncology, 25, 4.
  • Ramakers-van Woerden, N.L., Beverloo, H.B., Veerman, A.J., Camitta, B.M., Loonen, A.H., van Wering, E.R., Slater, R.M., Harbott, J., Den Boer, M.L., Ludwig, W.D., Haas, O.A., Janka-Schaub, G.E. & Pieters, R. (2004) In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype. Leukemia, 18, 521529.
  • Reiter, A., Schrappe, M., Tiemann, M., Parwaresch, R., Zimmermann, M., Yakisan, E., Dopfer, R., Bucsky, P., Mann, G., Gadner, H. & Riehm, H. (1994) Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. Journal of Clinical Oncology, 12, 899908.
  • Reiter, A., Schrappe, M., Parwaresch, R., Henze, G., Muller-Weihrich, S., Sauter, S., Sykora, K.W., Ludwig, W.D., Gadner, H. & Riehm, H. (1995) Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage–a report of the Berlin-Frankfurt-Munster Group. Journal of Clinical Oncology, 13, 359372.
  • Reiter, A., Schrappe, M., Tiemann, M., Ludwig, W.D., Yakisan, E., Zimmermann, M., Mann, G., Chott, A., Ebell, W., Klingebiel, T., Graf, N., Kremens, B., Muller-Weihrich, S., Pluss, H.J., Zintl, F., Henze, G. & Riehm, H. (1999) Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood, 94, 32943306.
  • Reiter, A., Schrappe, M., Ludwig, W.D., Tiemann, M., Parwaresch, R., Zimmermann, M., Schirg, E., Henze, G., Schellong, G., Gadner, H. & Riehm, H. (2000) Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood, 95, 416421.
  • Sandlund, J.T., Downing, J.R. & Crist, W.M. (1996) Non-Hodgkin's lymphoma in childhood. New England Journal of Medicine, 334, 12381248.
  • Sather, H.N. (1986) Age at diagnosis in childhood acute lymphoblastic leukemia. Medical and Pediatric Oncology, 14, 166172.
  • Sather, H., Miller, D., Nesbit, M., Heyn, R. & Hammond, D. (1981) Differences in prognosis for boys and girls with acute lymphoblastic leukaemia. Lancet, 1, 739743.
  • Seidemann, K., Tiemann, M., Schrappe, M., Yakisan, E., Simonitsch, I., Janka-Schaub, G., Dorffel, W., Zimmermann, M., Mann, G., Gadner, H., Parwaresch, R., Riehm, H. & Reiter, A. (2001) Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood, 97, 36993706.
  • Stansfeld, A.G., Diebold, J., Noel, H., Kapanci, Y., Rilke, F., Kelenyi, G., Sundstrom, C., Lennert, K., van Unnik, J.A., Mioduszewska, O. & Wright, D.M. (1988) Updated Kiel classification for lymphomas. Lancet, 1, 292293.
  • Tubergen, D.G., Krailo, M.D., Meadows, A.T., Rosenstock, J., Kadin, M., Morse, M., King, D., Steinherz, P.G. & Kersey, J.H. (1995) Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group Study. Journal of Clinical Oncology, 13, 13681376.
  • Williams, D.M., Hobson, R., Imeson, J., Gerrard, M., McCarthy, K. & Pinkerton, C.R. (2002) Anaplastic large cell lymphoma in childhood: analysis of 72 patients treated on the United Kingdom Children's Cancer Study Group chemotherapy regimens. British Journal of Haematology, 117, 812820.
  • Woessmann, W., Seidemann, K., Mann, G., Zimmermann, M., Burkhardt, B., Oschlies, I., Ludwig, W.D., Klingebiel, T., Graf, N., Gruhn, B., Juergens, H., Niggli, F., Parwaresch, R., Gadner, H., Riehm, H., Schrappe, M. & Reiter, A. (2005) The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms – a report of the BFM group study NHL-BFM95. Blood, 105, 948958.